WallStreetZenWallStreetZen

NASDAQ: SGMO
Sangamo Therapeutics Inc Stock Ownership - Who owns Sangamo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sangamo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2025-11-242,544$0.42
$1.06kSell
Sandy MacRaePRESIDENT CEO AND DIRECTOR2025-11-247,488$0.42
$3.12kSell
Scott B. WilloughbySVP CHIEF LEGAL OFFICER SECY2025-11-242,035$0.42
$848.59Sell
Gregory D. DavisHead of Research Technology2025-11-24723$0.42
$301.49Sell
Nikunj JainPrincipal Accounting Officer2025-11-24578$0.42
$241.03Sell
Prathyusha DuraibabuPRINCIPAL FINANCIAL OFFICER2025-11-242,544$0.42
$1.06kSell
Prathyusha DuraibabuPRINCIPAL FINANCIAL OFFICER2025-10-2245,225$0.66
$29.85kSell
Sandy MacRaePRESIDENT CEO AND DIRECTOR2025-10-22126,950$0.66
$83.79kSell
Gregory D. DavisHead of Research Technology2025-10-226,708$0.66
$4.43kSell
Nikunj JainPrincipal Accounting Officer2025-10-226,708$0.66
$4.43kSell

1 of 5

SGMO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMO insiders and whales buy or sell their stock.

SGMO Shareholders

What type of owners hold Sangamo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Biogen Inc5.25%17,652,466$8.76MInsider
Vanguard Group Inc3.45%11,615,150$5.76MInstitution
Renaissance Technologies LLC3.03%10,182,463$5.05MInstitution
Blackrock Inc1.35%4,556,208$2.26MInstitution
Ra Capital Management LP1.09%3,683,002$1.83MInsider
Gsa Capital Partners LLP1.09%3,662,478$1.82MInstitution
Geode Capital Management LLC0.98%3,286,476$1.63MInstitution
Two Sigma Investments LP0.74%2,479,186$1.23MInstitution
Susquehanna International Group LLP0.72%2,420,366$1.20MInstitution
Jane Street Group LLC0.65%2,200,685$1.09MInstitution

1 of 3

SGMO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMO18.60%9.54%Net SellingNet Selling
CDXS47.13%52.87%Net BuyingNet Selling
MOLN9.58%0.00%
IPHA0.09%0.00%
ACTU28.22%71.78%Net Buying
View Top Biotech Stocks

Sangamo Therapeutics Stock Ownership FAQ

Who owns Sangamo Therapeutics?

Sangamo Therapeutics (NASDAQ: SGMO) is owned by 18.60% institutional shareholders, 9.54% Sangamo Therapeutics insiders, and 71.85% retail investors. Biogen Inc is the largest individual Sangamo Therapeutics shareholder, owning 17.65M shares representing 5.25% of the company. Biogen Inc's Sangamo Therapeutics shares are currently valued at $8.76M.

If you're new to stock investing, here's how to buy Sangamo Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.